DOI: 10.36347/sjams.2018.v06i11.047

Pages: 4422-4427

Breast cancer is the leading cause of cancer in women worldwide hence it is important to understand its its demographic trends. This study has attempted to analyse the age at presentation, stage of the disease and hormone receptor status in patients with breast cancer which could help make strategies to hasten the process of diagnosis of the diasease at an early stage of the disease. This is an observational chart based study involving female patients aged above 18 years of age who were diagnosed with either invasive or in situ breast cancer. A sample size of 200 was calculated with mean age calculated as 51.74+_ 12.317 years. In our study the women with breast cancer had a maximum density in the age group of 40 to 55 years. In the age group of 25-40 years, of the 42 women diagnosed with breast cancer 25 of them belonged to stage 2 disease. In the ages between 40 to 55 years, 63 women had stage 2 diseases. Even in the age group of 55-70 and above 70 years maximum density of patients is again seen in stage 2 disease. The estrogen receptor(ER) status in women below forty years showed a ER negative trend as compared to women above 40 years which showed a ER positive trend. Progesterone receptor (PR) status in the women below forty years showed a PR positive status against women above forty years which showed a more PR negative status. The HER 2 NEU receptor study showed more HER 2 NEU negative status in both groups of women. It can be concluded that breast cancer is more aggressive in younger women. Hence the stage at presentation of the disease will help understand the disease etiology and plan management policies.